High-grade cervical cancer tends to show decreased expression of Sts-2 Visual inspection of the data reveals a conspicuous decline in mortality rates among patients with heightened Sts-2 expression, indicative of an associative trend between augmented Sts-2 levels and reduced fatality proportions ( Fig. 1A and B ).
← all excerpts
Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer.
1
—
—